Have a personal or library account? Click to login
The Burden of Infections with Extended Spectrum Beta-Lactamase-Producing Pathogen on Home Health Care Services Cover

The Burden of Infections with Extended Spectrum Beta-Lactamase-Producing Pathogen on Home Health Care Services

Open Access
|Feb 2026

Abstract

BACKGROUND

Extended-spectrum beta-lactamase (ESBL) producing pathogens are a growing health threat due to their resistance to most of the commonly used antimicrobial agents.

AIM

In this paper, we aimed to assess the prevalence of those pathogens among patients who received care in the home parenteral antimicrobial therapy program. We also aimed to examine the burden of those pathogens on the home health care services and discuss the options to minimize this burden.

METHODS

This retrospective cohort study was conducted in the Adult Home Health Care Service at King Abdulaziz Medical City in Riyadh, Saudi Arabia. We studied all patients referring to the home health care parenteral antimicrobial program in the period from January 1, 2019 to December 31, 2021. Patients' data were retrieved from their electronic medical records. We classified patients as a patient with ESBL infection and a patient with a non-ESBL infection based on their cultures.

RESULTS

A total of 253 patients, of whom 144 (56.9%) were females, were accepted into the home parenteral antimicrobial therapy during the specified period. Of these, 121 (47.8%) were treated with an infection with ESBL-producing bacteria. Escherichia coli (92.76.0%) and Klebsiella pneumoniae (23.19.0%) were the most commonly isolated ESBL pathogens. Female gender, a previous history of UTI or ESBL infection, cognitive impairment and BPH in men were all associated with a higher rate of ESBL infections (P<0.05). Infection caused by ESBL-producing pathogen was not associated with a significantly increased rate of complications, readmission or mortality (P≥0.05).

CONCLUSION

Almost half of the patients treated in the home parenteral antimicrobial program are infected with an ESBL producing pathogens. However, we did not find any significant increase in adverse clinical outcomes associated with those infections in our sample. The burden on the HHC services that comes with these infections is mostly related to the limited choices of antimicrobials and to the high rate of recurrence.

Language: English
Page range: 11 - 14
Submitted on: Feb 24, 2025
|
Accepted on: Dec 5, 2025
|
Published on: Feb 26, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2026 Amjad S. Al Seraya, Kholoud Abdulaziz Bin Haikel, published by Scientific Foundation SPIROSKI
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.